BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dimethyl fumarate (Tecfidera) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Dimethyl fumarate (Tecfidera)\, from Clin
 icalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04292080-5944@assetmemo.bio
DTSTAMP:20261121T005009Z
DTSTART;VALUE=DATE:20270407
DTEND;VALUE=DATE:20270408
SUMMARY:Dimethyl fumarate (Tecfidera): Phase 2 readout est. (NCT04292080)
DESCRIPTION:Dimethyl fumarate (Tecfidera)\, phase 2.\nStudy: Long-Term Anal
 ysis of DImethyl Fumarate\, to Slow the Growth of Areas of Geographic Atro
 phy\nEstimated primary completion: 7 April 2027. This is a ClinicalTrials.
 gov estimate\, not a confirmed readout date\, and it can move.\nDrug page:
  https://assetmemo.bio/drug/dimethyl-fumarate-tecfidera#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT04292080
URL:https://assetmemo.bio/drug/dimethyl-fumarate-tecfidera#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
